Study of Placental Function in Healthy and Pathological Pregnancies
This observational study aims to create a collection of human placentas, umbilical cord blood, and maternal blood samples at the time of delivery. Researchers will use these samples to understand how changes in the placenta (the organ that develops in your uterus during pregnancy) can lead to serious pregnancy problems and affect a baby's health later in life, potentially increasing their risk for metabolic and heart diseases. The study is looking for women aged 18 to 45 who are having healthy pregnancies or those with complications like preterm birth, restricted baby growth, diabetes, or obesity. The main goal is to collect and store these samples for 50 years. The current recruitment status is unclear.
- Study design
- This is an observational study with a planned enrollment of 1250 participants. It is not specified if it is randomized or blinded.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Specimens will be stored for 50 years in a repository, but it is not specified if participants will have follow-up after delivery.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Study of Placental Function in Healthy and Pathological Pregnancies
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Thomas Jansson, MD, PhD · PRINCIPAL_INVESTIGATOR · University of Colorado, Denver
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Collecting, processing, and archiving human specimens from 1250 subjectsSpecimens will be stored for 50 years in repository
Human placental tissue, umbilical cord blood, and maternal blood samples will be collected from pregnant women at the time of their delivery. The samples will be used to enhance understanding of the role of the placenta in the development of pregnancy complications and in programming of adult disease.